Literature DB >> 1325657

Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.

W Zhang1, A C Young, M Imarai, S G Nathenson, J C Sacchettini.   

Abstract

To study the structure of a homogenous major histocompatibility complex (MHC) class I molecule containing a single bound peptide, a complex of recombinant mouse H-2Kb, beta 2-microglobulin (beta 2m), and a fragment of the vesicular stomatitis virus (VSV) nuclear capsid protein, VSV-(N52-59) octapeptide (Arg-Gly-Tyr-Val-Tyr-Gln-Gly-Leu), was prepared by exploiting a high-yield bacterial expression system and in vitro cocomplex formation. The structure of mouse H-2Kb revealed its similarity to three human class I HLA molecules, consistent with the high primary sequence homology and common function of these peptide-presenting molecules. Electron density was located in the peptide-binding groove, to which a single peptide in a unique conformation was unambiguously fit. The peptide extends the length of the groove, parallel to the alpha-helices, and assumes an extended, mostly beta-strand conformation. The peptide is constrained within the groove by hydrogen bonding of its main-chain atoms and by contacts of its side chains with the H-2Kb molecule. The amino-terminal nitrogen atom of the peptide forms a hydrogen bond with the hydroxyl group of Tyr-171 of H-2Kb at one end of the groove, while the carboxyl-terminal oxygen forms a hydrogen bond with the hydroxyl group of Tyr-84 at the other end. Since the amino acids at both ends are conserved among human and mouse MHC molecules, this anchoring of each end of the peptide appears to be a general feature of peptide-MHC class I molecule binding and imposes restrictions on its length. The side chains of residues Tyr-3, Tyr-5, and Leu-8 of the VSV octapeptide fit into the interior of the H-2Kb molecule with no appreciable surface exposure, a finding in support of previous biological studies that showed the importance of these residues for binding. Thus, the basis for binding of specific peptide sequences to the MHC class I molecule is the steric restriction imposed on the peptide side chains by the architecture of the floor and sides of the groove. The side chains of Arg-1, Val-4, and Gln-6 and the main-chain of Gly-7 of the octapeptide are exposed on the surface of the complex, thus confirming their availability for T-cell receptor contact, as previously demonstrated by T-cell recognition experiments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325657      PMCID: PMC49927          DOI: 10.1073/pnas.89.17.8403

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation.

Authors:  R A Henderson; H Michel; K Sakaguchi; J Shabanowitz; E Appella; D F Hunt; V H Engelhard
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

2.  HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.

Authors:  M L Wei; P Cresswell
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

3.  Crystallization and preliminary X-ray diffraction studies of the human major histocompatibility antigen HLA-B27.

Authors:  J C Gorga; D R Madden; J K Prendergast; D C Wiley; J L Strominger
Journal:  Proteins       Date:  1992-01

4.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

5.  Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.

Authors:  T N Schumacher; M T Heemels; J J Neefjes; W M Kast; C J Melief; H L Ploegh
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

6.  Allogeneic and associative recognition determinants of H-2 molecules.

Authors:  S S Clark; J Forman
Journal:  Transplant Proc       Date:  1983-12       Impact factor: 1.066

Review 7.  Primary structural: analysis of the transplantation antigens of the murine H-2 major histocompatibility complex.

Authors:  S G Nathenson; H Uehara; B M Ewenstein; T J Kindt; J E Coligan
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

8.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

9.  The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides.

Authors:  G M van Bleek; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  Vesicular stomatitis virus antigenic octapeptide N52-59 is anchored into the groove of the H-2Kb molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus.

Authors:  K Shibata; M Imarai; G M van Bleek; S Joyce; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more
  67 in total

1.  The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain.

Authors:  D Housset; G Mazza; C Grégoire; C Piras; B Malissen; J C Fontecilla-Camps
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

2.  Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94.

Authors:  T J Nieland; M C Tan; M Monne-van Muijen; F Koning; A M Kruisbeek; G M van Bleek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Description of two new HLA-C alleles in a black South African population.

Authors:  G Minevich; L Kuhn; C Polistena; J Nuara; R Winchester
Journal:  Tissue Antigens       Date:  2007-10-29

Review 4.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

5.  Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes.

Authors:  J E Gairin; H Mazarguil; D Hudrisier; M B Oldstone
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

6.  Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.

Authors:  R A Colbert; S L Rowland-Jones; A J McMichael; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

7.  Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus.

Authors:  C E Hioe; D M McKinney; J A Frelinger; M McMillan
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

Authors:  J Hammer; C Belunis; D Bolin; J Papadopoulos; R Walsky; J Higelin; W Danho; F Sinigaglia; Z A Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Neelam Dhiman; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

10.  Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands.

Authors:  Y Ghendler; M K Teng; J H Liu; T Witte; J Liu; K S Kim; P Kern; H C Chang; J H Wang; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.